Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Before we address the future of compounded semaglutide, it’s essential to understand what compounding entails. Compounding pharmacies create custom formulations of medications to meet the unique needs of individual patients. This practice is especially useful for those who may require a specific dos
Regulatory Changes and the End of the Shortage
On February 21, 2025, the FDA officially announced that the shortage of semaglutide had ended. This decision marked a turning point for compounded semaglutide, as it meant that pharmacies could no longer compound the medication for general use. The FDA’s stance was based on the need to ensure patient safety and to uphold the integrity of the pharmaceutical market.
According to the FDA, the end of the shortage means that compounding pharmacies must cease the regular production of compounded semaglutide. They have been given specific deadlines to comply with this regulation, effectively cutting off the supply of compounded versions that many patients have relied upon.
For those who have been using compounded semaglutide, the implications of this regulatory change are significant. Patients now face the possibility of losing access to a medication that has been instrumental in their weight loss efforts. As we navigate this transition, it’s crucial for individuals to understand their options and what steps they can take to maintain their treatment plans.
At PlexusDx, we are committed to providing personalized weight loss solutions that align with PlexusDx's values of empathy, innovation, and transparency. As such, we encourage anyone affected by these changes to explore PlexusDx's personalized weight loss programs, which include FDA-approved medications and comprehensive support.
The Future of Semaglutide: What Lies Ahead?
As we move forward, patients currently using compounded semaglutide must consider their next steps. One crucial action is to consult with healthcare providers to discuss alternative options. While compounded versions may no longer be available, there are still FDA-approved medications that can help individuals manage their weight effectively.
For those who may have been using compounded semaglutide due to cost concerns, it’s essential to explore available resources, including patient assistance programs that pharmaceutical companies offer. At PlexusDx, we understand the challenges that come with accessing effective weight loss treatments, and we are here to help navigate these options.
With the discontinuation of compounded semaglutide, patients should consider transitioning to FDA-approved options. These may include:
-
Ozempic®: An injectable medication that is FDA-approved for weight management and diabetes control.
-
Wegovy®: Specifically designed for chronic weight management, this FDA-approved medication is a weekly injection that has shown significant results in clinical studies.
-
Other GLP-1 Agonists: Medications such as Mounjaro® and Zepbound® have emerged as alternatives in the GLP-1 class, offering similar benefits.
While the costs of these branded medications may be higher than compounded versions, it’s crucial to weigh the potential benefits against the risks associated with compounded alternatives.
FAQ
What will happen to those currently using compounded semaglutide?
Why did the FDA decide to stop compounded semaglutide production?
What are the alternatives to compounded semaglutide?
How can I access FDA-approved weight loss medications?
What should I do if I can no longer afford branded medications?
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What will happen to those currently using compounded semaglutide?
Patients using compounded semaglutide should consult with their healthcare providers to explore alternative FDA-approved options, as compounded versions will no longer be available.
Why did the FDA decide to stop compounded semaglutide production?
The FDA determined that the shortage of semaglutide had ended and aimed to ensure patient safety by regulating the use of compounded medications.
What are the alternatives to compounded semaglutide?
Alternatives include FDA-approved medications such as Ozempic®, Wegovy®, Mounjaro®, and Zepbound®.
How can I access FDA-approved weight loss medications?
You can consult with healthcare providers or explore personalized weight loss programs, such as those offered by PlexusDx, to access effective treatments tailored to your needs.
What should I do if I can no longer afford branded medications?
Consider reaching out to patient assistance programs provided by pharmaceutical companies or discussing alternative therapies with your healthcare provider to maintain your treatment plan.
Related Reading
Pricing and availability current as of May 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Decoding Tirzepatide: Understanding How Many Units Is the Starting Dose and Your Weight Loss Journey
Does Insurance Cover Ozempic for Weight Loss? Understanding Your Options